The Medical journal of Australia, 2(11), 523-525 (1982-11-27)
Mebhydrolin napadisylate is an antihistamine marketed in Australia as Fabahistin, and as an ingredient of Fabahistin Plus. Since June, 1973, 11 Australian reports associating this drug with either agranulocytosis or neutropenia have been received by the Adverse Drug Reactions Advisory
Rossiiskii fiziologicheskii zhurnal imeni I.M. Sechenova, 86(12), 1669-1675 (2001-02-24)
Administration of the acetylcholine esterase antagonist aminostigmin increased the number of neutrophils in the estrus phase and the number of lymphocytes in the diestrus phase in rats. Histamine decreased both the neutrophils and lymphocytes at all stages of the estrus
International journal of clinical pharmacology and therapeutics, 33(7), 373-383 (1995-07-01)
The efficacy of a multiple oral dose treatment with mebhydroline (Omeril coated tablets, 100 mg t.i.d.) was examined in 3 studies which were performed in a randomized, double-blind and placebo-controlled 2-way cross-over design. A second target was to investigate the
Farmakologiia i toksikologiia, 43(1), 62-65 (1980-01-01)
The effect of antihistaminic drugs, histamine and their combinations on the development of anaphylactic shock and the period of repeated resolution doses was studied in rabbit experiments. It was established that administration of dimedrol during sensibilization aggravated while diazolin and
This study investigated whether obesity, diabetes, and other metabolic factors are independently associated with hepatocellular carcinoma (HCC), stratified by hepatitis B virus (HBV) and hepatitis C virus (HCV) serostatus, and explored the possible joint influence of obesity/diabetes and HBV/HCV infections
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
